Cargando…
Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta‐analysis update
OBJECTIVE: To evaluate the diagnostic performance of short state homeobox 2 (SHOX2) promoter methylation as biomarker for lung cancer identification through aggregating the open published data. METHODS: We did an electronic search in Pubmed, EMBASE, Ovid, Web of Science, Google Scholar, and the Chin...
Autores principales: | Zhou, Xiaoxi, Lu, Xiaoling, Wu, Haiyan, Liu, Juan, Huang, He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671898/ https://www.ncbi.nlm.nih.gov/pubmed/34741433 http://dx.doi.org/10.1111/1759-7714.14206 |
Ejemplares similares
-
Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
por: Zhao, Qing-Tao, et al.
Publicado: (2015) -
The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022) -
APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta‐analysis
por: Liu, Fang, et al.
Publicado: (2021) -
SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
por: Schmidt, Bernd, et al.
Publicado: (2010) -
A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and
Serum Biomarker for Early Stage Lung Cancer
por: Huang, Wenhai, et al.
Publicado: (2020)